News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 325–360
- Matches
- 2771
- Sources here
- 20
- Companies here
- 25
Active search
2771 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Why (WF) Price Action Is Critical for Tactical Trading
Woori Financial Group Inc. (NYSE: WF) is exhibiting a near-term neutral sentiment amidst mid and long-term strength, characterized by a mid-channel oscillation pattern. AI models suggest an exceptional 44.5:1 risk-reward setup, targeting a 12.9% gain against a 0.3% risk. Three distinct trading strategies—Position Trading, …
Woori Financial Group, Inc. Financial Disclosures & Filings
This page provides access to Woori Financial Group, Inc.'s financial disclosures and regulatory filings, including quarterly and annual earnings reports. Investors can review documents dating back to 2014 to understand the company's performance, strategy, and capital management. Recent reports highlight robust capital, stable asset …
Birgit Girshick Sells 6,500 Shares of Charles River Laboratories International (NYSE:CRL) Stock
Birgit Girshick, CEO of Charles River Laboratories International (NYSE:CRL), sold 6,500 shares of the company's stock for approximately $1.82 million. This transaction, executed under a Rule 10b5-1 trading plan, reduced her ownership by 15.29%. The company recently reported strong quarterly EPS and revenue that …
Charles River Laboratories International (NYSE:CRL) EVP Sells $1,038,657.24 in Stock
Charles River Laboratories International's EVP, Shannon Parisotto, sold 3,714 shares of company stock for approximately $1.04 million, reducing her holdings by 43.59%. This transaction was conducted under a pre-arranged Rule 10b5-1 plan. The company recently reported adjusted earnings of $3.02 per share, exceeding estimates, …
Charles River Laboratories International Inc. stock underperforms Thursday when compared to competitors
Charles River Laboratories International Inc. (CRL) stock fell 1.09% to $281.27 on Thursday, despite a positive trading session for the broader market. This underperformance snapped a seven-day winning streak for the company's shares. The S&P 500 Index rose 0.65%, and the Dow Jones Industrial …
Charles River Labs (CRL) CEO exercises 6,500 options and sells shares under 10b5-1 plan
Charles River Laboratories (CRL) CEO Birgit Girshick exercised stock options for 6,500 shares on August 11, 2026, at an exercise price of $179.66 per share. Simultaneously, she sold these 6,500 common shares at $279.90 per share. These transactions were conducted under a pre-arranged Rule …
Charles River (CRL) executive Parisotto exercises options, sells 3,714 shares under 10b5-1 plan
Shannon M. Parisotto, CEVP, Discovery & Safety Assessment at Charles River Laboratories International, exercised stock options for 3,714 shares at $179.66 per share and simultaneously sold the same number of shares at $279.66 per share. These transactions, executed on August 11, 2026, were conducted …
Seacoast Banking Corporation of Florida (SBCF) Earnings Forecast: Future EPS & Revenue Growth Estimates
Seacoast Banking Corporation of Florida (SBCF) has an earnings forecast score of 6.67, ranking 232 out of 395 in the Banking Services industry. The average price target from 6 analysts is $33.25, with a "Hold" rating. The company's expected revenue for the next quarter …
Primoris Services (PRIM): Wellington Group discloses 4.68M-share, 8.6% ownership stake
Wellington Management Group LLP and its affiliated entities have reported a beneficial ownership stake of 4,675,487 shares, representing 8.62% of Primoris Services Corporation (PRIM) common stock, as of June 30, 2026. The shares are held by clients of Wellington's investment advisers, who possess shared …
Kayne Anderson Rudnick (BFAM) discloses 5.5% Bright Horizons stake in 13G/A
Kayne Anderson Rudnick Investment Management, LLC has filed an amended Schedule 13G, disclosing a beneficial ownership of 5.5% in Bright Horizons Family Solutions Inc. This stake amounts to 2,879,927 shares of common stock as of June 30, 2026. The filing details the firm's sole …
Harvey Authement, Jr. Joins First Horizon Bank As Banking Center Manager In Houma
HOUMA, La., Aug. 13, 2026 /PRNewswire/ -- First Horizon Bank (NYSE: FHN or "First Horizon") is pleased to announce that Harvey Authement, Jr. has joined the company as Banking Center Manager of the First Horizon Houma Banking Center at 706 Barrow St.Harvey Authement, Jr. …
Invesco reports 2.98M-share stake in Charles River Laboratories (CRL)
Invesco Ltd., a Bermuda-based parent holding company, has reported a significant passive ownership position in Charles River Laboratories International, Inc. (CRL) common stock. The firm beneficially owns 2,984,785 shares, representing 6.2% of the outstanding common stock, held by its investment advisory clients. Invesco maintains …
Silicon Labs Q2 FY 2026: IoT Recovery Builds Momentum for Series 3 Platform
Silicon Labs reported strong Q2 FY 2026 earnings, showing sequential improvements in revenue, gross margin, and profitability, indicating a recovery in the IoT semiconductor sector. The company's new 22nm Series 3 platform is central to its strategy of moving into more complex, compute-heavy, and …
Orion Energy Systems (OESX) director awarded 2,532 restricted shares in equity grant
Orion Energy Systems director Heather L. Wishart-Smith was granted 2,532 restricted shares of common stock on August 11, 2026, as an equity award under the company’s 2016 Omnibus Incentive Plan. These shares will vest in three equal installments on August 11, 2027, 2028, and …
Core Laboratories (NYSE:CLB) Stock Rating Upgraded by Johnson Rice
Johnson Rice upgraded Core Laboratories (NYSE:CLB) from a "hold" to a "buy" rating, setting a $21.00 price target. This upgrade implies a significant upside, although the broader analyst consensus remains "Hold." The company recently reported better-than-expected EPS but missed revenue estimates, while its CEO …
Invesco Discovery Fund's Primoris Services Corp(PRIM) Holding History
This article details the historical holdings of Invesco Discovery Fund in Primoris Services Corp (PRIM). As of May 31, 2026, the fund held no shares of PRIM, having made 5 purchases and 2 sales since initial trading in Q4 2024. The fund's estimated gain …
Dr. Reddy’s Laboratories (RDY) CEO API & Services Deepak Sapra resigns effective November 12, 2026
Dr. Reddy’s Laboratories announced that Deepak Sapra, CEO of API & Services and a Senior Management Personnel, has resigned to pursue outside opportunities. His resignation is effective November 12, 2026, and he will remain with the company until then to ensure a smooth transition …
Silicon Labs: Medical Revenue Surges 78% To Record As IoT Design Wins Accelerate
Silicon Labs reported a record 78% year-over-year increase in Medical revenue for Q2, driven by accelerating IoT design wins and stronger demand across its portfolio. Total Q2 revenue rose 18% to $228 million, with significant growth in Industrial & Commercial and Home & Life …
Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research
Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …
Tim Truels Hansen Sells 25,000 Shares of Dorian LPG (NYSE:LPG) Stock
Tim Truels Hansen, an insider at Dorian LPG (NYSE:LPG), sold 25,000 shares of the company's stock for over $1.1 million, reducing his direct stake by nearly 14%. This sale follows strong quarterly earnings where Dorian LPG exceeded revenue and EPS estimates, alongside a positive …
What's Backing Abbott's Established Pharmaceuticals Division Growth
Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …
Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle
Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …
Sharemaestro market context Price above Trend Line 52 weeks -1.0% · Next-week setup positive 57.3%Dorian LPG CCO Tim Hansen sells over $1.1 million in shares
Tim Truels Hansen, Chief Commercial Officer of DORIAN LPG LTD. (NASDAQ:LPG), sold 25,000 common shares for over $1.1 million on August 11, 2026. This sale follows a significant 97% year-to-date surge in the company's stock price. Despite the sale, Hansen retains a substantial holding, …
DORIAN LPG (LPG) Chief Commercial Officer sells 25,000 shares at $45.044
DORIAN LPG's Chief Commercial Officer, Tim Truels Hansen, sold 25,000 common shares at $45.044 per share on August 11, 2026. Following this transaction, Hansen now holds 157,675 common shares, which include 28,547 unvested restricted stock units. The sale amounted to approximately $1.13 million.
Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More
This article details Wall Street analyst upgrades, downgrades, and initiations for various companies on Thursday, August 13, 2026, following the release of inline CPI data. Key movements include Five Below being upgraded to Buy at Jefferies and StubHub being cut to Underperform at Bank …